Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy.

Authors:
Miao L; Lu C; Zhang B; Li H; Zhao X and 3 more

Journal:
J Transl Med

Publication Year: 2024

DOI:
10.1186/s12967-024-05033-w

PMCID:
PMC10909296

PMID:
38433193

Journal Information

Full Title: J Transl Med

Abbreviation: J Transl Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declared that no competing interest exists. Competing interests The authors declared that no competing interest exists."

Evidence found in paper:

"Funding This research was funded by Xiaonan Cui, the host of the Capacity Construction Project of Major Clinical (specialized) Departments of Traditional Chinese Medicine of Liaoning Province (No.LNZYXZK201909), and the host of the Distinguished Professor Program of Liaoning Province. And Ying Liu, the host of the Hospital Research Fund by Affiliated Zhongshan Hospital of Dalian University (No.20230320)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025